GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Price-to-Owner-Earnings

Starton Therapeutics (Starton Therapeutics) Price-to-Owner-Earnings : (As of May. 26, 2024)


View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Price-to-Owner-Earnings?

As of today (2024-05-26), Starton Therapeutics's share price is $0.00. Starton Therapeutics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Starton Therapeutics's Price-to-Owner-Earnings or its related term are showing as below:


STA's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.37
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-26), Starton Therapeutics's share price is $0.00. Starton Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00. Therefore, Starton Therapeutics's PE Ratio for today is N/A.

As of today (2024-05-26), Starton Therapeutics's share price is $0.00. Starton Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in was $0.00. Therefore, Starton Therapeutics's PE Ratio without NRI for today is N/A.


Starton Therapeutics Price-to-Owner-Earnings Historical Data

The historical data trend for Starton Therapeutics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Price-to-Owner-Earnings Chart

Starton Therapeutics Annual Data
Trend Mar21 Mar22 Mar23
Price-to-Owner-Earnings
- - -

Starton Therapeutics Quarterly Data
Mar21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Starton Therapeutics's Price-to-Owner-Earnings

For the Biotechnology subindustry, Starton Therapeutics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Starton Therapeutics's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starton Therapeutics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Starton Therapeutics's Price-to-Owner-Earnings falls into.



Starton Therapeutics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Starton Therapeutics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Starton Therapeutics  (NAS:STA) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Starton Therapeutics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Starton Therapeutics (Starton Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
215 College Road, Suite No.300, Paramus, NJ, USA, 07652
Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines